Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 20, Issue 4, Pages 1009-1013Publisher
IOS PRESS
DOI: 10.3233/JAD-2010-100087
Keywords
Alzheimer's disease; amyloid-beta; amyloid-beta protein precursor; audiogenic seizure; Down syndrome; metabotropic glutamate receptor 5
Categories
Funding
- National Institutes of Health [R01DA026067, P30 HD03352]
- Alzheimer's Drug Discovery Foundation
- FRAXA Research Foundation
- Bill and Doris Willis
- EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026067] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Amyloid-beta protein precursor (A beta PP) is overexpressed in Alzheimer's disease (AD), Down syndrome (DS), autism, and fragile X syndrome. Seizures are a common phenotype in all of these neurological disorders, yet the underlying molecular mechanism(s) of seizure induction and propagation remain largely unknown. We demonstrate that AD(Tg2576) and DS (Ts65Dn) mice exhibit audiogenic seizures, which can be attenuated with antagonists to metabotropic glutamate receptor 5 (mGluR5) or by passive immunization with anti-amyloid-beta antibody. Our data strongly implicates A beta PP or a catabolite in seizure susceptibility and suggests that mGluR(5) mediates this response.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available